Novo Nordisk A/S (NYSE:NVO) is one of the Most Undervalued International Stocks According to Analysts. On August 19, TD Cowen ...

We live in a world where $1 billion of prescription medications are left at the pharmacy counter each year, often because ...

Q: My sister’s 16-year-old son is getting heavy, and I want to say something to her about the health risks so she can help ...

As the patent for semaglutide nears its end, Novo Nordisk's dominance in the weight-loss market is being challenged. The ...

Serena Williams recently shared that she started taking the GLP-1 drug Zepbound after having her two children. The tennis ...

Learn about the use of GLP-1 agonists for weight loss and health improvement by celebrities like Oprah and Serena Williams.

Dentists claim weight-loss drugs could majorly impact users' saliva glands, helping gum disease to fester in their mouths.

Wegovy is now approved by FDA for the treatment of adults with noncirrhotic MASH with moderate to advanced liver fibrosis.

Williams is not the first sportsperson to promote GLP-1 weight loss medication but she is the most high profile and easily ...

The small study followed patients for six months and found that 54 percent experienced a reduction in their symptoms after taking a GLP-1RA. Most of the patients had type 2 diabetes and the median BMI ...

Under brand names like Ozempic and Wegovy, semaglutide-based medications have made a significant difference in treating type ...